Segal Lloyd Mitchell 4
4 · Repare Therapeutics Inc. · Filed Mar 14, 2025
Insider Transaction Report
Form 4
Segal Lloyd Mitchell
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Shares
2025-03-12$1.14/sh−21,179$24,144→ 124,394 total
Holdings
- 107,558(indirect: See footnote)
Common Shares
Footnotes (2)
- [F1]Represent shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting and settlement of restricted stock units and does not represent a discretionary sale by the holder.
- [F2]These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.